Sensorion News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.05.23	Sensorion Publishes Results of Combined Shareholders’ General Meeting Resolutions (Businesswire)
11.05.23	Sensorion Will Present Two Posters At The American Society Of Cell And Gene Therapy (ASGCT) 26th Annual Meeting (Businesswire)
03.05.23	Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 24, 2023 (Businesswire)
24.04.23	Sensorion to Host a Symposium during ISIET’s International Symposium on Inner Ear Therapeutics on April 30, 2023 (Businesswire)
18.04.23	Sensorion to participate in Chardan’s Annual Genetic Medicines & Cell Therapy Manufacturing Summit and Kempen’s Life Sciences Conference (Businesswire)
06.04.23	Sensorion Announces Candidate Selection for GJB2 Gene Therapy Program (Businesswire)
31.03.23	Sensorion Appoints Khalil Barrage as Interim Chairman of the Board (Businesswire)
30.03.23	Sensorion Announces the Publication of Its 2022 Annual Financial Report (Businesswire)
16.03.23	Sensorion Reports Full-Year 2022 Financial Results and Business Update (Businesswire)
13.03.23	Sensorion Discloses No Exposure To Silicon Valley Bank Closure (Businesswire)
07.03.23	Sensorion to Participate in the 6th Annual Bioprocessing Summit Europe (Businesswire)
27.02.23	Sensorion Further Strengthens Leadership, Appoints David Lawrence as Chief Financial Officer (Businesswire)
21.02.23	Sensorion announces R&D Day focusing on its Gene Therapy programs (Businesswire)
02.02.23	Sensorion Will Present Two Posters at the Association for Research in Otolaryngology ARO 46th Annual MidWinter Meeting (Businesswire)
31.01.23	Sensorion and EVEON Collaborating to Develop an Injection System for the Delivery of Gene Therapy Treatments Into the Inner Ear (Businesswire)
05.01.23	Sensorion Will Take Part in a Press Conference Launching the Annual UNESCO Week of Sound (Businesswire)
03.01.23	Sensorion Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity (Businesswire)
05.12.22	Sensorion Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting in San Francisco (Businesswire)
30.11.22	Sensorion receives Orphan Drug Designation for OTOF-GT for the treatment of otoferlin gene-mediated hearing loss from the US Food and Drug Administration (Businesswire)
07.11.22	Sensorion Announces US FDA Grants Rare Pediatric Disease Designation to OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss (Businesswire)
24.10.22	Sensorion Announces Approval to Initiate amended Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity in France (Businesswire)
06.10.22	Sensorion to Present at the European Society of Gene & Cell Therapy (ESGCT) and the Gene Therapy for Rare Disorders Europe conferences in October 2022 (Businesswire)
26.09.22	Sensorion to Participate in Various Upcoming Investor Conferences (Businesswire)
22.09.22	Sensorion Reports 2022 First Half Results (Businesswire)
14.09.22	Sensorion Announces First Patient Enrolled in Proof-of-Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation (Businesswire)
12.09.22	Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss From the European Medicine Agency (Businesswire)
08.09.22	Sensorion to participate in the Inner Ear Biology Workshop in September 2022 (Businesswire)
07.07.22	Sensorion to Present at the Gene Therapy Neurological Disorders Europe, CASSS Bioassays Symposium and Cell & Gene Therapy Summit Conferences in July 2022 (Businesswire)
01.07.22	Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation (Businesswire)
24.06.22	Sensorion to Participate in the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 29, 2022 (Businesswire)
15.06.22	Sensorion to Present at the Inner Ear Disorder Therapeutics Summit in June 2022 (Businesswire)
09.06.22	Sensorion to Present at the Gene Therapy Development and Manufacturing Conference in June 2022 (Businesswire)
07.06.22	Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation (Businesswire)
01.06.22	Sensorion Publishes Results of Combined General Meeting Resolutions (Businesswire)
12.05.22	Sensorion to Attend the American Society of Gene & Cell Therapy (ASGCT) and Gene Therapy Analytical Development Conferences in May 2022 (Businesswire)
10.05.22	Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022 (Businesswire)
28.04.22	Sensorion Announces the Publication of Its 2021 Annual Financial Report (Businesswire)
28.04.22	Sensorion Full-Year 2021 Financial Results and Business Highlights (Businesswire)
21.04.22	Sensorion Will Participate in Chardan’s 6th Annual Genetic Medicines and Cell Therapy Manufacturing Summit Held Virtually on April 26, 2022 (Businesswire)
15.04.22	Sensorion Publishes Results of Extraordinary General Meeting Resolutions (Businesswire)
12.04.22	Sensorion to Attend the Kempen Life Sciences, Cell & Gene Meeting on the Mediterranean Conferences in April 2022 (Businesswire)
25.03.22	Sensorion Will Present at The H.C. Wainwright Gene Therapy and Gene Editing Virtual Conference on March 30th, 2022 (Businesswire)
24.03.22	Sensorion Provides Preliminary Documents for the Extraordinary General Meeting of April 14th, 2022 (Businesswire)
18.03.22	Sensorion Will Present at the Bioprocessing Summit Europe Conference on March 22, 2022 in Barcelona (Businesswire)
17.03.22	Sensorion Update on SENS-401 (Businesswire)
03.02.22	Sensorion to Present Three Posters on SENS-401 in Cisplatin Ototoxicity Models at the Association for Research in Otolaryngology (ARO) 45th Annual MidWinter Meeting (Businesswire)
01.02.22	Sensorion to Present New Data on OTOF Gene Therapy at the Association for Research in Otolaryngology ARO 45th Annual MidWinter Meeting (Businesswire)
17.01.22	Sensorion Updates on SENS-401 Phase 2 trial in Sudden Sensorineural Hearing Loss (Businesswire)
10.06.21	Sensorion Appoints Gene Therapy and Rare Disease Expert Nora Yang as Chief Scientific Officer (Businesswire)
27.05.21	Sensorion to Attend Two Conferences in June 2021 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Sensorion SA

Aktien Top/Flop

Meistgelesene Nachrichten